1. Bringing diarrhea under CONTROL: dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer. (April 2021) Authors: Ruiz-Borrego, M.; Chan, A.; Marx, G.; Brufsky, A.; Trudeau, M.; Egle, D.; McCulloch, L.; Tripathy, D.; Barcenas, C.H. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of metformin on progression-free survival outcomes in patients with advanced or metastatic HR+, HER2– breast cancer: subgroup analysis of STEPAUT. (March 2017) Authors: Egle, D.; Marth, C.; Steger, G.; Bartsch, R.; Pfeiler, G.; Greil, R.; Helfgott, R.; Öhler, L.; Hennebelle, M.; Gnant, M. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?. (April 2023) Authors: Wimmer, K.; Hlauschek, D.; Balic, M.; Pfeiler, G.; Strobl-Kacerovsky, S.; Greil, R.; Singer, C.F.; Halper, S.; Steger, G.; Suppan, C.; Gampenrieder, S.P.; Helfgott, R.; Egle, D.; Filipits, M.; Jakesz, R.; Sölkner, L.; Fesl, C.; Gnant, M.; Fitzal, F. Journal: Breast Issue: Volume 68(2023)Supplement Page Start: S123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PRO Hair Safe Study: The patient's perspective on the effects of scalp cooling on hair preservation. (November 2022) Authors: Brunner, C.; Egle, D.; Ritter, M.; Kofler, R.; Pichler, B.; Sztankay, M.; Schneitter, L.; Giesinger, J.; Abdel Azim, S.; Oberguggenberger, A. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Real-World multicenter Austrian analysis of the safety and effectiveness of nab-paclitaxel in young and elderly patients with metastatic breast cancer. (April 2018) Authors: Steger, G.; Petru, E.; Haslbauer, F.; Marth, C.; Egle, D.; Galid, A.; Sliwa, T.; Lang, A.; Kuehr, T.; Petzer, A.; Ruckser, R.; Greil, R.; Mlineritsch, B.; Singer, C.; Seifert, M.; Andel, J.; Kwasny, W.; Pichler, P.; Tinchon, C.; Bartsch, R. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centres. (November 2017) Authors: Badbanchi, F.; Catalano, G.; Cretella, E.; Daniaux, M.; Emons, A.; van Eygen, K.; Ettl, J.; Gatzemeier, W.; Kern, P.; Schneeweiss, A.; Stoeblen, F.; Van As, A.; Wuerstlein, R.; Zanini, V.; van Dam, P.A.; Tomatis, M.; Marotti, L.; Heil, J.; Mansel, R.E.; Rosselli del Turco, M. Journal: European journal of cancer Issue: Volume 85(2017) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗